Literature DB >> 2498071

Serotonin mediates suppression of focal epileptiform activity induced by noxious stimulation.

R S Neuman1, P M Thompson.   

Abstract

Noxious stimulation can suppress epileptic seizures in humans and epileptiform activity in laboratory animals. Using as a model system the focal epileptiform activity (FEA) induced by the pneumophoresis of penicillin, the role of 5-hydroxytryptamine (5HT) in suppression of this activity by noxious stimulation was investigated. Drugs known to depress dorsal raphe unit activity, (+/-)-8-hydroxydipropylaminotetralin (DPAT), imipramine, and fluoxetine prevented suppression of FEA induced by noxious stimulation. Desimipramine, which depresses locus ceruleus but not dorsal raphe unit activity, was ineffective in blocking the suppression. Quipazine, an agonist at 5-HT receptors, in part restored the suppression that had been blocked by DPAT or imipramine. Several serotonin antagonists effective at 5-HT1 and 5-HT2 receptors blocked suppression, but an unequivocal determination of the serotonin receptor subtype mediating suppression could not be made. We conclude that 5-HT mediates suppression of FEA induced by noxious stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498071     DOI: 10.1111/j.1528-1157.1989.tb05302.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

1.  Urethane reduces contraction to 5-hydroxytryptamine (5-HT) and enhances the action of the 5-HT antagonist ketanserin on the rat thoracic aortic ring.

Authors:  H C Dringenberg; C H Vanderwolf; J T Hamilton
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  The diverse role of the raphe 5-HTergic systems in epilepsy.

Authors:  He-Ming Cheng; Chen-Shu Gao; Qiu-Wen Lou; Zhong Chen; Yi Wang
Journal:  Acta Pharmacol Sin       Date:  2022-05-25       Impact factor: 6.150

Review 3.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.